Angioimmunoblastic lymphadenopathy associated with polyarthritis

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) is a rare T-cell lymphoma.
• AILD often presents with systemic symptoms and immune dysregulation.

Observation:

• A patient with AILD experienced severe hemolytic anemia following polyarthritis and gold therapy.
• In vitro tests revealed suppressed cell-mediated immunity and the presence of serum antismooth muscle antibodies.

Findings:

• The patient's unusual presentation supports an immunological basis for AILD.
• Combined therapy with prednisone and azathioprine led to clinical improvement.

Implications:

• This case highlights the potential benefit of combined immunosuppressive therapy in select AILD patients.
• The development of lymphoma post-AILD underscores the importance of ongoing monitoring.